                               SEQUENCE LISTING

<110> REGENERON PHARMACEUTICALS, INC.
 
<120> METHODS FOR BINDING SITE IDENTIFICATION USING HYDROGEN EXCHANGE 
      MASS SPECTROMETRY

<130> 070816-01922

<140> PCT/US2021/049975
<141> 2021-09-11

<150> 63/077,220
<151> 2020-09-11

<160> 13    

<170> PatentIn version 3.5

<210> 1  
<211> 7
<212> PRT
<213> Homo sapiens

<400> 1
Glu Leu Leu Gly Gly Pro Ser 
1               5           


<210> 2
<211> 8
<212> PRT
<213> Homo sapiens

<400> 2
Lys Thr His Thr Cys Pro Pro Cys 
1               5               


<210> 3
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Gly Ala Gly His Met Val Pro Thr Asp Lys Pro Arg 
1               5                   10          


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Leu Phe Pro Glu Tyr Lys 
1               5       


<210> 5
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Leu Tyr Gln Ser Met Asn Ser Gln Tyr Leu Lys 
1               5                   10      


<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Gly Leu Glu Asp Ser Tyr Glu Gly Arg 
1               5                   


<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Gln Asn Leu Asp Pro Pro Val Ser Arg 
1               5                   


<210> 8
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Ser Val Leu Leu Asp Ala Ala Ser Gly Gln Leu Arg 
1               5                   10          


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Phe Leu Ser Thr Leu Thr Ile Asp Gly Val Thr Arg 
1               5                   10          


<210> 10
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Ser Asp Gln Gly Leu Tyr Thr Cys Ala Ala Ser Ser Gly Leu Met Thr 
1               5                   10                  15      


Lys 
    


<210> 11
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Ser Asp Thr Gly Arg Pro Phe Val Glu Met Tyr Ser Glu Ile Pro Glu 
1               5                   10                  15      


Ile Ile His Met Thr Glu Gly Arg 
            20                  


<210> 12
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Leu Thr Ile Asp Gly Val Thr Arg Ser Asp Gln Gly Leu Tyr Thr Cys 
1               5                   10                  15      


Ala 
    


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 13
Pro Ala Pro Glu Leu Leu Gly 
1               5           


